We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

March 26, 2020

Digital Therapeutics, Clinical Trials, Barcelona

Events
Chandana Fitzgerald
&
Hanna Phelan

HealthXL and Almirall were lucky to  have had a chance to run this event back in February in person in Barcelona prior to the COVID-19 escalation, and wish everybody in Spain and beyond well during these tough times. Below is a roundup of the discussions we had with some of the prominent leaders in health.

Connecting with digital health leaders and learning the current processes shaping the industry is at the centre of all our events. HealthXL Global Gathering in Barcelona was an invite-only event of the world’s leading healthcare innovators. 

We focused the discussions on two key themes - educating each other about the opportunities Barcelona presents in being a conducive health hub, and asking some of the ‘real’ questions on digital therapeutics payment models.

Barcelona as a Digital Health Hub

What we learnt: 



Barcelona is not only known for its architecture, food and beaches, but also for its advancements in biotech research, healthcare services and a thriving start-up scene. In this session we explored through the eyes of the local movers and shakers why Barcelona is the right place to be for digital health, what opportunities it presents, and outline some of the successes to date.

Frederic Llordachs, Co-founder of Doctoralia, shed light on the successes of his company’s clinical connection service and the facilitative environment for this success found in Barcelona. The strong Barcelona pull factors were also energetically highlighted by Mateu Hernandez CEO of Barcelona Global who made an excellent case for the affordability, accessibility and research acumen drawing in the global community of digital health innovators. Barcelona was flagged as being highly accessible for the large hospitals to open their own innovation departments as it is more affordable than other cities in Europe - serving as an excellent test bed for innovations in a real world environment and providing a reasonably priced, highly educated workforce.

A testament to the potential of Barcelona was the quickfire showcase of the first cohort selected for the Almirall Digital Garden. These first start-ups have been chosen for the 9-month acceleration program based in the beautiful and historical settings of the Barcelona Health Hub.

The Digital Garden powered by Almirall, allows startups focused on developing innovative technology-based services and solutions to play a relevant role in tackling dermatology challenges. Led by Francesca Wuttke, CDO of Almirall, the Digital Garden differentiates from other accelerators by taking no equity in the companies accepted into the program and has been built for success by closely studying other programs working to accelerate startup innovations elsewhere in the sector.  Internal leaders from various groups at Almirall serve as voluntary mentors to these start-ups as well. 

This first cohort will be ready to graduate to Venture funding in September armed with complete business cases and a partnership willingness and know-how.This session made a strong case to all stakeholder groups for coming to Barcelona for a business card and not just a postcard! While Jorge Fernandez, Director of Innovation at EIT was also positive about the potential of Barcelona as a focal point for digital health development, areas for improvement were also flagged, including the need for increased transformative initiatives and a breakdown of legacy silos of expertise. 


We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Digital Therapeutics: Modalities of Deployment and How to Get Paid 

What we learnt: 

The excitement around promising new modalities enabling the delivery of much needed DTx offerings was matched with a realisation around all the unknowns that still remain around DTx reimbursement and regulation. The recent German Digital Health Act was mentioned by multiple panelists and speakers as being a potentially promising precedent for other European countries to follow as a framework. 

Dr John Reeves CEO and Founder of Conversation Health and Tommy Kok Annfeldt of Biogen gave an insightful presentation on how Life Sciences are starting to leverage voice enabled DTx solutions. Three fundamental ways that conversational AI will power DTx according to Dr Reeves will be: 

  1. Newfound access, reach and frequency of clinical insights and interaction
  2. Transformation from flat text to deeper meaningful interactive conversations
  3. AI will complement current services with the aim of cutting costs and increasing coverage 

It was recognised by the group of experts we had on stage and in the audience that DTx holds the potential to take out a lot of cost from the system by meaningfully treating comorbidities but there remains a concern that it has become a buzzword. 



The DTx state of the nation panel saw some hard hitting questions fielded by Lisa Suennen to some very capable panelists in the form of Jessica Shull, Digital Therapeutics Alliance, Celine Ullman, Almirall, and Anish Shindore, Sanofi. Who is being reimbursed? What pathways have they taken and how can the successes and failures be truly translated into action. We walked away learning that we probably need to ask the payment questions sooner than later, and that DTx companies should start befriending health economic outcomes studies.

Beats Medical, Kaia Health, Psious and Bold Health - all featured in the DTx innovators panel discussion described how they are navigating the health plan space via either self pay or co-pay by their insurer. There was consensus that we need to try and think integratively in light of these traditional pathways. We need to combine the tech, the service economics and the context of the patient continually. This signals a shift in new dynamics of the relationship between patients, caregivers and physicians. 


We aspire to continue these very necessary and relevant conversations albeit perhaps virtually in the coming months. We were glad to have had a chance to run this event in person in Barcelona prior to the COVID-19 escalation, and wish everybody in Spain well during these tough times.

HERE is a lighter version with pictures, anecdotes and speakers from the day. 


We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

HealthXL events have gone virtual

With COVID-19’s uncertainty across the globe, we hear daily about events getting cancelled. But it is more important now than ever to stay connected with the right people. 

Share insights, connect, collaborate and benefit from:

Contact us today for more information.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx last mile delivery - HCPs and patients adoption

2nd November @ 11:45AM EDT

Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx. Apply now to connect with peers and learn from fellow thought leaders in this space.

Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Tech Giants, Start-ups or Incumbents, who will disrupt healthcare?

4th November @ 11:30AM EDT

Join our Digital Health Meeting as discuss How do we define disruption in the healthcare industry? What is the ‘extinction event’ healthcare needs and why has it not happened yet? And what are the learnings from Tech Giants’ moves in healthcareApply now to join the conversation and share your thoughts on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
AI in Healthcare
AI in Healthcare
AI in Healthcare
AI in Healthcare

Masterclass: AI-based diagnostics - learnings from a real-world use case

21st October @ 9:00AM GMT

In this masterclass, Zachary Tan (Advisor at CancerAid; Venture Creation Partner at Aegis Ventures; more info here) & Lisa Zhu (Research Fellow of the Center for Eye Research Australia) will walk us through the key learnings from their latest article in Scientific Reports (Nature) on real-world AI-based screening for diabetic retinopathy in Australia. This early-stage study is one of the first globally to describe the real-world implementation of AI in healthcare.

Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology

Digital Health in Mental Health: Commercialization Models

21st October @ 10:45AM EDT

Join us in this informal conversation where we will discuss the best commercialisation models for digital companies in the mental health space. Our 75 minute sessions are guaranteed to be filled with interesting debate and great conversation.

Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices
Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.